The use of IL-1 alpha and beta inhibition with ARCALYST has increasingly become the preferred treatment for recurrent ...

Among adults and adolescents with cystic fibrosis starting triple therapy for the first time, inflammatory markers fell and ...

Study shows social isolation following immune challenge is self-imposed and driven by an active neural process, rather than a secondary consequence of physiological symptoms of sickness.

"I just can't make it tonight. You have fun without me." Across much of the animal kingdom, when infection strikes, social contact shuts down. A new study details how the immune and central nervous ...

Kineret blocks the biologic activity of IL-1 alpha and beta by competitively inhibiting IL-1 binding to the IL-1 type I receptor. The Food and Drug Administration (FDA) has approved the supplemental ...